Login
$BMY
$62.93 +$0.00 (0.0%) After hours

$BMY 8-K/A SEC Filings

Filed On Filing
31 Oct 2023 8-K/A: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

05 Feb 2020 8-K/A: Completion of Acquisition or Disposition of Assets

We have audited the accompanying consolidated balance sheets of Celgene Corporation and subsidiaries (the Company) as of December 31, 2018 and 2017, and the related consolidated statements of income, comprehensive income, cash flows, and...

11 Dec 2019 8-K/A: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

20 Apr 2015 8-K/A: Departure/Election of Directors or Officers; Compensation

(b) (c) On January 23, 2015, Bristol-Myers Squibb Company (the “Company”) filed a Form 8-K to disclose, among other things, the retirement of Lamberto Andreotti as Chief Executive Officer and his election as Chairman of the Board, effect...

06 Mar 2015 8-K/A: Departure/Election of Directors or Officers; Compensation

(b) (c) On January 23, 2015, Bristol-Myers Squibb Company (the “Company”) filed a Form 8-K to disclose that on January 20, 2015, the Company announced the retirement of James M. Cornelius from the Company’s Board of Directors, the retire...

01 Aug 2008 8-K/A: Other Events

Welcome, ladies and gentlemen, to today’s Bristol-Myers Squibb investor relations conference call. This call is being recorded. Later, there will be a question and answer session.

19 Feb 2008 8-K/A: Results of Operations and Financial Condition

On January 31, 2008, Bristol-Myers Squibb Company (the “Company”) filed a Form 8-K furnishing its press release that announced the Company’s financial results for the fourth quarter and full year ended December 31, 2007 and incorporating...

30 Nov 2007 8-K/A: Results of Operations and Financial Condition

quarterly amounts may not add to the year-to-date totals due to rounding of individual calculations.

31 Aug 2007 8-K/A: Results of Operations and Financial Condition

quarterly amounts may not add to the year-to-date totals due to rounding of individual calculations.

27 Aug 2007 8-K/A: Results of Operations and Financial Condition

On April 26, 2007, Bristol-Myers Squibb Company (the “Company”) filed a Form 8-K furnishing its press release that announced the Company’s financial results for the first quarter of 2007 and incorporating it therein by reference. Also fu...

26 Jul 2007 8-K/A: Results of Operations and Financial Condition

This table presents Total Company sales on a legal entity source basis and segment and product sales on a country management reported basis.

31 May 2007 8-K/A: Results of Operations and Financial Condition

amounts may not calculate due to rounding differences between continuing and discontinued operations.

30 Nov 2006 8-K/A: Results of Operations and Financial Condition

amounts may not calculate due to rounding differences between continuing and discontinued operations.

30 Oct 2006 8-K/A: Results of Operations and Financial Condition

amounts may not calculate due to rounding differences between continuing and discontinued operations.

31 May 2006 8-K/A: Results of Operations and Financial Condition

amounts may not calculate due to rounding differences between continuing and discontinued operations.

17 Apr 2006 8-K/A: Changes in Registrant's Certifying Accountant

As previously reported, on March 14, 2006, the Audit Committee of the Board of Directors of Bristol-Myers Squibb Company (the “Company”) appointed Deloitte & Touche LLP (“D&T”) as the independent registered public accounting firm (“audit...

17 Apr 2006 8-K/A: Changes in Registrant's Certifying Accountant

As previously reported, on March 14, 2006, the Audit Committee of the Board of Directors of Bristol-Myers Squibb Company (the “Company”) appointed Deloitte & Touche LLP (“D&T”) as the independent registered public accounting firm (“audit...

17 Apr 2006 8-K/A: Changes in Registrant's Certifying Accountant

As previously reported, on March 14, 2006, the Audit Committee of the Board of Directors of Bristol-Myers Squibb Company (the “Company”) appointed Deloitte & Touche LLP (“D&T”) as the independent registered public accounting firm (“audit...

13 Jan 2006 8-K/A: Departure/Election of Directors or Officers; Compensation

On January 10, 2006, Louis J. Freeh was appointed to the Audit Committee and the Committee on Directors and Corporate Governance of the Registrant’s Board of Directors. As previously reported on Form 8-K filed on September 13, 2005, Mr. ...

01 Dec 2005 8-K/A: Results of Operations and Financial Condition

Includes alliance revenue from the co-promotional agreement with Otsuka Pharmaceutical Co., Ltd.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support